RTW INVESTMENTS, LP - 31 Mar 2026 SCHEDULE 13G/A Report for Stoke Therapeutics, Inc. Common Stock, par value $0.0001 per share (STOK)

Filing Manager: RTW INVESTMENTS, LP
Reporting Manager: RTW Investments, LP
Security: Stoke Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: STOK
Shares outstanding: 60,008,747 shares
Disclosed Ownership: 5,940,866 shares
Ownership: 9.9%
Form type: SCHEDULE 13G/A
Filing time: 15 May 2026, 08:32:20 UTC
Date of event: 31 Mar 2026
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Key filing fact

RTW INVESTMENTS, LP disclosed 9.9% ownership in Stoke Therapeutics, Inc. Common Stock, par value $0.0001 per share (STOK) on 31 Mar 2026.

Key facts

RTW INVESTMENTS, LP filed SCHEDULE 13G/A for Stoke Therapeutics, Inc. Common Stock, par value $0.0001 per share (STOK).
Disclosed ownership: 9.9%.
Date of event: 31 Mar 2026.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
RTW Investments, LP	9.9%	5,940,866	0	5,940,866	/s/ Roderick Wong, M.D.	Roderick Wong, M.D., Managing Partner
Roderick Wong	9.9%	5,940,866	0	5,940,866	s/ Roderick Wong, M.D.	Roderick Wong, M.D.

CIK / CUSIP context first

Broader feeds